Dergiler / ENT Updates / 2019 / Cilt: 9 - Sayı: 2

The Incidence And Severity Of Frey’s Syndrome After Parotidectomy: A Retrospective Study

Sayfa
74–80
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

By this means, clinicians can make more accurate definitions for indications of preventive procedures as well as treatment approaches.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study was to investigate the incidence and severity of Frey’s syndrome (FS) among parotidectomy patients and to assess the impact of parotidectomy sequelae on quality of life (QoL).
📊
Temel Bulgular & Veri:Methods: In total, 43 patients (21 males, 22 females) who underwent parotidectomy were included in this study.
💡
Sonuç & Katkı:By this means, clinicians can make more accurate definitions for indications of preventive procedures as well as treatment approaches.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The aim of this study was to investigate the incidence and severity of Frey’s syndrome (FS) among parotidectomy patients and to assess the impact of parotidectomy sequelae on quality of life (QoL). Methods: In total, 43 patients (21 males, 22 females) who underwent parotidectomy were included in this study. Iodine-starch test was applied to identify the presence and the severity of FS. The results were evaluated using a previously described grading system. Patients’ perceptions of parotidectomy sequelae were graded to identify their impact on QoL and also if there is an association between the extent of parotidectomy, the time elapsed after surgery and the severity of symptoms. Results: FS was diagnosed in 18 (41.8%) patients, 10 of which (23.3%) reported having FS symptoms. Of all patients who were diagnosed with FS, 11 (61.2%) patients’ symptoms were classified as mild, whereas 7 (38.8%) were classified as severe. There was no significant correlation between the incidence of FS and the time between surgery and diagnosis, or the extent of parotidectomy. Among all symptoms reported by patients, FS was the sequelae that caused the most discomfort after parotidectomy. Conclusion: The negative impact of FS on QoL is restricted to cases with severe symptoms, the incidence of which is rare and independent of the extent of surgery. To avoid overtreatment, true incidence of FS remains to be identified in study samples from different centers. By this means, clinicians can make more accurate definitions for indications of preventive procedures as well as treatment approaches.

🔖

Bu Makaleye Atıf Yap

DALOĞLU, M., GÜNEY, K. (2019). The Incidence And Severity Of Frey’s Syndrome After Parotidectomy: A Retrospective Study. ENT Updates, Cilt: 9 - Sayı: 2, 74–80. https://ajindex.com/articles/150765

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Erkan SO, Tuhanioglu B, Erkan ZA, Güney Z, Taş ZA. Parotid mass: Toxoplasma lenfadenitis. ENTcase 2017;2:325
  2. Ford FR, Woodhall B. Phenomena due to misdirection of regenerating fibers of cranial, spinal and automatic nerves. Arch Surg 1938;38:480-96
  3. Gardner WJ, McCubbin JW. Auriculotemporal syndrome; gustatory sweating due to misdirection of regenerated nerve fibers. J Am Med Assoc 1956;160:272-7
  4. Laccourreye O, Muscatelo L, Naude C et al. Botulinum toxin type A for Frey’s syndrome: a preliminary prospective study. Ann Otol Rhinol Laryngol 1998;107:52-5
  5. Rustemeyer J, Eufinger H, Bremerich A. The incidence of Frey’s syndrome. J Craniomaxillofac Surg 2008;36:34-7
  6. Minor V. Ein neues Verfahren zu der klinischen Untersuchung der Schweißabsonderung. [Article in German] Deutsche Zeitschrift für Nervenheilkunde 1928;101:302-8
  7. Farrell ML, Kalnins IK. Frey’s syndrome following parotid surgery. Aust N Z J Surg 1991;61:295-301
  8. Gordon AB, Fiddian RV. Frey’s syndrome after parotid surgery. Am J Surg 1976;132:54-8
  9. Linder TE, Hub 9. LinderTE,HuberA, Schmid S. Frey’s syndrome after parotidectomy: a retrospective and prospective analysis. Laryngoscope 1997;107:1496-501
  10. Xie S, Wang K, Xu T et al. Efficacy and safety of botulinum toxin type A for treatment of Frey’s syndrome: evidence from 22 published articles. Cancer Med 2015;4:1639-50
  11. Luna-Ortiz K, Sansón-RíoFrío JA, Mosqueda-Taylor A. Frey syndrome. A proposal for evaluatin severity. Oral Oncol 2004;40:501-5 12. Laage-Hellman JE. Gustatory sweating and flushing after conservative parotidectomy. Acta Otolaryngol 1957;48:234-52
  12. LaccourreyeH,Laccourreye O, Cauchois R et al. Total conservative parotidectomy for primary benign pleomorphic adenoma of the parotid gland: a 25-year experience with 229 patients. Laryngoscope 1994;104:1487-94
  13. Lafont M, Whyte A, Whyte J et al. Frey syndrome: factors influencing the time to event. Int J Oral Maxillofac Surg 2015;44:834-9
  14. Tuncel A, Karaman M, Sheidaei S et al. A comparison of incidence of Frey’s syndrome diagnosed based on clinical signs and Minor’s test after parotis surgery. Kulak Burun Bogaz Ihtis Derg 2012;22:200-6
  15. Dulguerov N, Makni A, Dulguerov P. The superficial musculoaponeurotic system flap in the prevention of Frey syndrome: A meta-analysis. Laryngoscope 2016;126:1581-4
  16. Sharma R. Prevention of Frey syndrome with superficial temporal fascia interpositioning: a retrospective study. Int J Oral Maxillofac Surg 20